LONG-TERM SAFETY AND EFFICACY OF EFGARTIGIMOD PH20 SC IN GENERALIZED MYASTHENIA GRAVIS: INTERIM ANALYSIS OF ANTI-ACETYLCHOLINE RECEPTOR ANTIBODY SERONEGATIVE PARTICIPANTS IN ADAPT-SC

被引：0
|
作者：
Bhavaraju-Sanka, Ratna
Howard, James F., Jr.
Vu, Tuan
De Bleecker, Jan L.
Utsugisawa, Kimiaki
Pasnoor, Mamatha
Sacca, Francesco
Korobko, Denis
Steeland, Sophie
Noukens, Jan
Van Hoorick, Benjamin
Liu, Li
Podhorna, Jana
Meisel, Andreas
Mantegazza, Renato
机构：
来源：
MUSCLE & NERVE | 2024年 / 70卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
144
引用
收藏
页码：516 / 517
页数：2
相关论文
共 27 条
  • [1] Long-term safety, and efficacy of subcutaneous Efgartigimod PH20 in patients with generalized myasthenia gravis: interim results of ADAPT-SC
    Musick, K.
    Howard, J.
    Li, G.
    Vu, T.
    Korobko, D.
    Smilowski, M.
    Liu, L.
    Steeland, S.
    Noukens, J.
    Van Hoorick, B.
    Podhorna, J.
    Li, Y.
    Utsugisawa, K.
    Sacca, F.
    Wiendl, H.
    De Bleecker, J.
    Mantegazza, R.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S179 - S179
  • [2] LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF SUBCUTANEOUS EFGARTIGIMOD PH20 IN PARTICIPANTS WITH GENERALIZED MYASTHENIA GRAVIS: INTERIM RESULTS OF THE ADAPT-SC plus STUDY
    Li, Yuebing
    Howard, James F., Jr.
    Vu, Tuan
    Korobko, Denis
    Steeland, Sophie
    Van Hoorick, Benjamin
    Podhorna, Jana
    Hodari, Moana
    Utsugisawa, Kimiaki
    Sacca, Francesco
    De Bleecker, Jan L.
    Mantegazza, Renato
    MUSCLE & NERVE, 2024, 70 (03) : 559 - 560
  • [3] Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod PH20 in Patients with Generalized Myasthenia Gravis: Interim Results of the ADAPT-SC plus Study
    Ritt, Elissa
    Howard, James F., Jr.
    Li, George
    Vu, Tuan
    Korobko, Denis
    Smilowski, Marek
    Liu, Li
    Steeland, Sophie
    Noukens, Jan
    Van Hoorick, Benjamin
    Podhorna, Jana
    Li, Yuebing
    Utsugisawa, Kimiaki
    Sacca, Francesco
    Wiendl, Heinz
    De Bleecker, Jan L.
    Mantegazza, Renato
    ANNALS OF NEUROLOGY, 2023, 94 : S244 - S245
  • [4] Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod PH20 in Patients with Generalized Myasthenia Gravis: Interim Results of the ADAPT-SC plus Study
    Howard, James
    Li, George
    Vu, Tuan
    Korobko, Denis
    Smilowski, Marek
    Liu, Li
    Steeland, Sophie
    Noukens, Jan
    Van Hoorick, Benjamin
    Podhorna, Jana
    Li, Yuebing
    Utsugisawa, Kimiaki
    Sacca, Francesco
    Wiendl, Heinz
    De Bleecker, Jan
    Mantegazza, Renato
    NEUROLOGY, 2023, 100 (17)
  • [5] EFFICACY, SAFETY, AND TOLERABILITY OF EFGARTIGIMOD IN ANTI-ACETYLCHOLINE RECEPTOR AUTOANTIBODY SERONEGATIVE PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: INTEGRATED INTERIM ANALYSIS OF ADAPT/ADAPT
    Vu, Tuan
    Bril, Vera
    Karam, Chafic
    Peric, Stojan
    De Bleecker, Jan
    Murai, Hiroyuki
    Pasnoor, Mamatha
    Sacca, Francesco
    Meisel, Andreas
    Guglietta, Antonio
    T'joen, Caroline
    Utsugisawa, Kimiaki
    Mantegazza, Renato
    Howard, James
    MUSCLE & NERVE, 2022, 66 : S54 - S55
  • [6] Subcutaneous efgartigimod PH20 in generalized myasthenia gravis: A phase 3 randomized noninferiority study (ADAPT-SC) and interim analyses of a long-term open-label extension study (ADAPT-SC plus )
    Howard Jr, James F.
    Vu, Tuan
    Li, George
    Korobko, Denis
    Smilowski, Marek
    Liu, Li
    Gistelinck, Fien
    Steeland, Sophie
    Noukens, Jan
    Van Hoorick, Benjamin
    Podhorna, Jana
    Borgions, Filip
    Li, Yuebing
    Utsugisawa, Kimiaki
    Wiendl, Heinz
    De Bleecker, Jan L.
    Mantegazza, Renato
    NEUROTHERAPEUTICS, 2024, 21 (05)
  • [7] EFFICACY, SAFETY, AND TOLERABILITY OF EFGARTIGIMOD IN ACETYLCHOLINE RECEPTOR AUTOANTIBODY SERONEGATIVE PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: INTEGRATED INTERIM ANALYSIS OF THE ADAPT AND ADAPT plus STUDIES
    Howard, James F., Jr.
    Bril, Vera
    Tuan Vu
    Karam, Chafic
    Peric, Stojan
    De Bleecker, Jan L.
    Murai, Hiroyuki
    Pasnoor, Mamatha
    Sacca, Francesco
    Meisel, Andreas
    Guglietta, Antonio
    T'joen, Caroline
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    MUSCLE & NERVE, 2022, 65 : S13 - S14
  • [8] COMBINED ANALYSES OF PARTICIPANTS WITH ANTI-ACETYLCHOLINE RECEPTOR SERONEGATIVE GENERALIZED MYASTHENIA GRAVIS TREATED WITH EFGARTIGIMOD ACROSS CLINICAL STUDIES
    Brauer, Edward
    Howard, James F., Jr.
    Vu, Tuan
    Mantegazza, Renato
    Meisel, Andreas
    Utsugisawa, Kimiaki
    Bril, Vera
    MUSCLE & NERVE, 2024, 70 (03) : 518 - 518
  • [9] Long-term Safety and Efficacy of Efgartigimod in Patients With Generalized Myasthenia Gravis: Interim Results of the ADAPT plus Study
    Howard, James
    Bril, Vera
    Vu, Tuan
    Karam, Chafic
    Peric, Stojan
    De Bleecker, Jan
    Murai, Hiroyuki
    Meisel, Andreas
    Beydoun, Said
    Pasnoor, Mamatha
    Guglietta, Antonio
    Ulrichts, Peter
    T'joen, Caroline
    Brauer, Edward
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    NEUROLOGY, 2022, 99 (23) : S37 - S38
  • [10] LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF EFGARTIGIMOD IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: INTERIM RESULTS OF THE ADAPT plus STUDY
    Howard, James F., Jr.
    Bril, Vera
    Tuan Vu
    Karam, Chafic
    Peric, Stojan
    De Bleecker, Jan L.
    Murai, Hiroyuki
    Meisel, Andreas
    Beydoun, Said
    Pasnoor, Mamatha
    Guglietta, Antonio
    T'joen, Caroline
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    MUSCLE & NERVE, 2022, 65 : S9 - S10
123